Are you Dr. Senzer?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 53 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3410 Worth St
Department Of Radiation Oncology
Dallas, TX 75246Phone+1 214-370-1400Fax+1 214-370-1405- Is this information wrong?
Summary
- Dr. Neil Senzer, MD is a radiation oncologist in Dallas, Texas. He is currently licensed to practice medicine in Texas. He is affiliated with Medical City Dallas.
Education & Training
St Barnabas Medical CenterResidency, Radiation Oncology, 1982 - 1985
University of TennesseeFellowship, Pediatric Hematology/Oncology, 1976 - 1978
Johns Hopkins UniversityResidency, Pediatrics, 1971 - 1974
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1971
Certifications & Licensure
TX State Medical License 1985 - 2018- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
- American Board of Radiology Therapeutic Radiology
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
Clinical Trials
- 131-I-TM-601 Study in Adults With Solid Tumors Start of enrollment: 2006 Aug 01
- Talimogene Laherparepvec in Patients With Unresectable Pancreatic Cancer Start of enrollment: 2006 Nov 01
- An Extension Study for Patients Previously Treated With ARQ 501 Start of enrollment: 2006 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- Corrigendum to "Gemogenovatucel-T (Vigil) immunotherapy demonstrates clinical benefit in homologous recombination proficient (HRP) ovarian cancer" [Gynecologic Oncolog...Rodney P Rocconi, Bradley J Monk, Adam Walter, Thomas J Herzog, Evanthia Galanis, Luisa Manning, Ernest Bognar, Gladice Wallraven, Laura Stanbery, Phylicia Aaron, Neil...> ;Gynecologic Oncology. 2023 Feb 1
- 2 citationsENTPD1/CD39 as a predictive marker of treatment response to gemogenovatucel-T as maintenance therapy in newly diagnosed ovarian cancer.Rodney P Rocconi, Laura Stanbery, Min Tang, Adam Walter, Bradley J Monk, Thomas J Herzog, Robert L Coleman, Luisa Manning, Gladice Wallraven, Staci Horvath, Ernest Bog...> ;Communications Medicine. 2022 Jan 1
- 18 citationsGemogenovatucel-T (Vigil) immunotherapy demonstrates clinical benefit in homologous recombination proficient (HRP) ovarian cancer.Rodney P. Rocconi, Bradley J. Monk, Adam Walter, Thomas J. Herzog, Evanthia Galanis, Luisa Manning, Ernest Bognar, Gladice Wallraven, Laura Stanbery, Phylicia Aaron, N...> ;Gynecologic Oncology. 2021 Mar 11
- Join now to see all
Hospital Affiliations
Medical City DallasDallas, Texas
